Bio Solution Co.,Ltd. (KOSDAQ:086820)
5,730.00
-160.00 (-2.72%)
At close: Oct 22, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 147.86 billion as of October 22, 2026. It is the 24,315th most valuable company in the world and the 1,005th biggest in South Korea. Its market cap has decreased by 24.07% in one year.
Market Cap
147.86B
Enterprise Value
155.39B
Revenue
17.39B
Global Rank
Country Rank
#1,005 South Korea
PE Ratio
162.64
ChartMarket Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 147.86B, a decrease of -32.27%. That is a compound annual growth rate of -4.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 147.86B | -22.67% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 209.98B |
| curacle co.,ltd. | 196.75B |
| Kangstem Biotech | 177.86B |
| NIBEC | 171.32B |
| ISU Abxis | 147.81B |
| Kanaph Therapeutics | 135.80B |
| Y-Biologics | 135.53B |
| Ensol Biosciences | 131.83B |